Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Non-Hodgkin's Lymphoma Therapeutics Market to Reach USD 18.6 Billion by 2034: Fuelled by New Drugs and Targeted Therapies | Latest Report by TMR

This image opens in the lightbox

News provided by

Transparency Market Research

01 Aug, 2024, 14:01 GMT

Share this article

Share toX

Share this article

Share toX

Investment in research and development for new and improved treatments is contributing to market growth.

WILMINGTON, Del., Aug. 1, 2024 /PRNewswire/ -- The Non-Hodgkin's lymphoma therapeutics market was projected to attain US$ 8.0 billion in 2023. It is likely to garner an 8.0% CAGR from 2024 to 2034, and by 2034, the market is expected to attain US$ 18.6 billion. Existing treatments may not be effective for all patients, creating a demand for new therapies. There is a shift towards personalized medicine with therapies targeting specific cancer cells or molecular pathways, such as monoclonal antibodies and kinase inhibitors.

The use of immune checkpoint inhibitors and CAR-T cell therapies is becoming more prevalent, offering new hope for NHL patients. Combining different therapeutic approaches (e.g., chemotherapy with targeted therapy) is gaining traction to improve efficacy and reduce resistance. Advances in biomarker identification are enhancing the ability to diagnose NHL early and tailor treatments to individual patients. Increased access to healthcare in emerging markets is expanding the availability of NHL therapies.

Download Sample of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2668

There is potential for significant growth in the market with the development of new drugs and therapies that address unmet needs. Initiatives that support patients through their treatment journey can enhance patient adherence and improve outcomes. Improved awareness and screening programs lead to earlier detection and diagnosis of NHL, increasing the demand for therapeutic options. Better understanding of the genetic basis of NHL enables the development of targeted therapies that are more effective and have fewer side effects.

Non-Hodgkin's Lymphoma Therapeutics Market Report Scope:

Report Coverage

Details 

Forecast Period  

2024-2034

Base Year  

2020-2022

Size in 2023

US$ 8.0 Bn

Forecast (Value) in 2034

US$ 18.6 Bn

Growth Rate (CAGR) 

8.0 %

No. of Pages 

145 Pages 

Segments covered 

By Treatment Therapy, By Indication Type, By Route of Administration, By Region, By End-user

Non-Hodgkin's Lymphoma Therapeutics Market: Key Players

The non-hodgkin's lymphoma therapeutics market is characterized by intense competition among pharmaceutical and biotechnology companies, driven by the demand for innovative and effective treatments. The following companies are well known participants in the non-hodgkin's lymphoma therapeutics market:

  • Mylan N.V.
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi S.A.
  • Pfizer Inc.
  • GSK plc
  • Novartis AG
  • Bayer AG
  • Eli Lilly and Company
  • Merck & Co. Inc.
  • AbbVie Inc.
  • AstraZeneca plc
  • Johnson & Johnson Pvt. Ltd.

Key Developments

  • In 2021, Kyowa Kirin Co., Ltd., in collaboration with MEI Pharma, Inc., announced the completion of patient enrollment for the Follicular Lymphoma Primary Efficacy Population in their global Phase 2 TIDAL study.
  • In the same year, Bristol-Myers Squibb Company announced that the U.S. FDA had approved their CAR-T cell therapy, Breyanzi, for the treatment of large B-cell lymphoma in patients who have relapsed or not responded after at least two other systemic treatments.

Key Findings of the Market Report

  • Innovations in imaging and diagnostic technologies, such as PET and MRI scans, facilitate more accurate disease staging and treatment planning.
  • The integration of digital health technologies, such as telemedicine and mobile health apps, enhances patient monitoring and management, leading to better outcomes.
  • Personalized treatment plans and patient-centric care models are gaining prominence, improving patient experiences and adherence to therapies.
  • There is a growing emphasis on managing long-term therapy effects and improving the quality of life for patients through supportive care and symptom management.

Market Trends for Non-Hodgkin's Lymphoma Therapeutics

  • By treatment therapy, the imunotherapy segment is expected to boost the growth of the non-hodgkin's lymphoma therapeutics market. Immunotherapy includes advanced treatments such as CAR-T cell therapy, immune checkpoint inhibitors, and monoclonal antibodies, which have shown significant promise in treating various types of NHL. These innovations offer new hope for patients who do not respond well to traditional therapies.
  • In terms of indication type, the B-cell lymphomas segment is anticipated to augment the growth of the non-hodgkin's lymphoma therapeutics market. B-cell lymphomas are more common compared to T-cell lymphomas, which translates to a larger patient population and a higher demand for therapeutic options. Significant advancements in treatments for B-cell lymphomas, such as CAR-T cell therapies (e.g., Kymriah and Yescarta) and novel monoclonal antibodies (e.g., Rituximab), have improved patient outcomes and increased market growth. 

Explore Sample of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2668

Global Market for Non-Hodgkin's Lymphoma Therapeutics: Regional Outlook

North America

  • North America has a high incidence and prevalence of NHL, leading to a significant patient population and increased demand for effective therapeutic options.
  • The region boasts a well-developed healthcare infrastructure, including state-of-the-art medical facilities, advanced diagnostic tools, and cutting-edge treatment options, which supports the growth of the NHL therapeutics market. 

Asia Pacific

  • The introduction and expansion of new treatments, including targeted therapies and immunotherapies, are becoming more accessible in Asia Pacific countries, driving market growth.
  • Growing awareness about NHL and improvements in diagnostic capabilities are leading to earlier diagnosis and treatment, boosting the demand for therapeutic solutions.

Non-Hodgkin's Lymphoma Therapeutics Market Segmentation

Treatment Therapy

  • Chemotherapy
  • Targeted Therapy
  • Immunotherapy
  • Others (Radiation Therapy, etc.)

Indication Type

  • B-Cell Lymphomas
  • T-Cell Lymphomas

Route of Administration

  • Oral
  • Parenteral

End User

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa 

Buy this Premium Research Report: https://www.transparencymarketresearch.com/checkout.php?rep_id=2668&ltype=S 

More Trending Report by Transparency Market Research:

  • Vaccines Market: The global vaccines market is projected to expand at a CAGR of 4.2% during the forecast period from 2023 to 2031
  • Laser Capture Microdissection Market: Market for Laser Capture Microdissection is expected to grow at a CAGR of 10.7% from 2024 to 2034 and reach US$ 739.6 Mn by the end of 2034
  • Electronic Health Records Market likely to surpass USD 50 Bn by 2031, expanding at a 5% CAGR
  • IV Bags Market Predicted to Reach USD 1.5 billion by 2032, Expanding at a CAGR of 5.8%

About Transparency Market Research 

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. 

Contact:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com 
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn | Twitter| Blog | YouTube

Logo: https://mma.prnewswire.com/media/1682871/TMR_Logo_Logo.jpg 

Modal title

Also from this source

Ultra-high Purity Anhydrous Hydrogen Chloride (HCl) Gas Market to Reach USD 5.7 Billion by 2031, Expanding at a CAGR of 5.4% | TMR Report

Ultra-high Purity Anhydrous Hydrogen Chloride (HCl) Gas Market to Reach USD 5.7 Billion by 2031, Expanding at a CAGR of 5.4% | TMR Report

Over the last year, several companies have announced new semiconductor fabrication sites, especially in the U.S., India, and Europe. These...

Silicon Metal Market Size Projected to Expand to USD 10.7 Billion by 2031 Exhibiting 5.1% CAGR: Transparency Market Research, Inc.

Silicon Metal Market Size Projected to Expand to USD 10.7 Billion by 2031 Exhibiting 5.1% CAGR: Transparency Market Research, Inc.

The market was valued at US$ 6.9 billion in 2022. The Silicon Metal Market Growth is estimated to reach US$ 10.7 billion by the end of 2031,...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Biotechnology

Biotechnology

Pharmaceuticals

Pharmaceuticals

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.